No results for ‘’
Lupin Ltd
₹2272.90
(0.38%)
Fri, 19 Jun 2026, 08:32 am
Health Technology
Pharmaceuticals: Other
24.5KLupin PB Ratio
| Particulars | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings ratio | 24.18 | 16.10 | 9.92 | 11.44 | 20.88 | 21.58 | 27.36 | 21.50 | 22.94 | 37.73 | 29.65 | 25.59 | 132.92 | 55.34 | 0 | 38.20 | 0 | 68.83 | 38.64 | 28.27 |
| Price to book ratio | 6.56 | 5.57 | 3.17 | 4.01 | 5.63 | 5.65 | 5.90 | 5.41 | 6.05 | 10.17 | 5.98 | 4.83 | 2.45 | 2.43 | 2.13 | 3.36 | 2.80 | 2.37 | 5.17 | 5.39 |
| Price to sales ratio | 2.42 | 2.43 | 1.50 | 1.52 | 3 | 3.26 | 3.41 | 2.99 | 3.80 | 7.20 | 4.86 | 3.85 | 2.15 | 2.33 | 1.76 | 3.09 | 2.08 | 1.80 | 3.76 | 4.17 |
| Price to cash flow ratio | 39.41 | 30.27 | 17.01 | 13.54 | 22.28 | 24.24 | 44.83 | 23.15 | 21.17 | 32.44 | 0 | 16.32 | 20.99 | 22.53 | 21.25 | 26.87 | 122.67 | 17.38 | 21.68 | 31.99 |
| Enterprise value | 4555Cr | 5368Cr | 4989Cr | 6900Cr | 15195Cr | 19403Cr | 25043Cr | 29017Cr | 41852Cr | 89043Cr | 73082Cr | 70578Cr | 38915Cr | 39010Cr | 28574Cr | 47542Cr | 36180Cr | 32490Cr | 74928Cr | 94105Cr |
| Enterprise value to EBITDA ratio | 19.58 | 17.75 | 10.63 | 6.34 | 17.12 | 17.91 | 18.24 | 13.36 | 14.37 | 24.78 | 19.50 | 16.54 | 6.54 | 16.57 | 13.06 | 18.52 | 17.19 | 19.42 | 21.11 | 19.31 |
| Debt to equity ratio | 1.49 | 0.99 | 0.94 | 0.86 | 0.44 | 0.35 | 0.41 | 0.22 | 0.09 | 0.06 | 0.64 | 0.59 | 0.53 | 0.62 | 0.53 | 0.37 | 0.34 | 0.37 | 0.20 | 0.32 |
| Return on equity % | 30.47 | 40.55 | 37.92 | 37.09 | 34.14 | 29.50 | 23.80 | 28.52 | 30.27 | 30.41 | 22.57 | 20.74 | 1.86 | 3.75 | -3.04 | 9.24 | -11.79 | 3.50 | 14.34 | 20.88 |
Lupin Ltd Price to Book Ratio
The Lupin Ltd Price to Book Ratio is a key financial metric used by investors to evaluate Lupin Ltd's valuation, profitability, and overall financial performance. Tracking the Lupin Ltd Price to Book Ratio helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.
Lupin Ltd (NSE: LUPIN, BSE: 500257) is currently trading at ₹2272.90, with a market capitalization of ₹102992.45Cr. As a leading company in the Health technology sector and Pharmaceuticals: other industry, monitoring the Lupin Ltd Price to Book Ratio is essential for fundamental analysis.
Lupin Ltd Price to Book Ratio Current Value
The current Lupin Ltd Price to Book Ratio stands at 5.39.
The latest Lupin Ltd Price to Book Ratio has increased compared to the previous period, indicating rising valuation or improved investor sentiment.
Lupin Ltd Price to Book Ratio Historical Trend
The Lupin Ltd Price to Book Ratio has shown the following historical trend:
- 2024: 5.39
- 2023: 5.17
- 2022: 2.37
- 2021: 2.80
- 2020: 3.36
The recent rise in Lupin Ltd Price to Book Ratio suggests strengthening valuation trends and improving market sentiment.
What Lupin Ltd Price to Book Ratio Indicates for Investors
The Lupin Ltd Price to Book Ratio plays a crucial role in understanding the company's financial health and valuation.
The P/B ratio shows how the market values company assets relative to book value.
Lupin Ltd Price to Book Ratio Analysis Summary
The Lupin Ltd Price to Book Ratio remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Lupin Ltd Price to Book Ratio should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.
Regular tracking of Lupin Ltd Price to Book Ratio helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.